药物对比
Linagliptin vs Insulin Degludec
比较 Linagliptin（Tradjenta）与 Insulin Degludec（Tresiba）治疗2型糖尿病。口服药与胰岛素：疗效、低血糖风险、体重影响。
此页面暂无可用的对比维度。
临床背景
This comparison arises when intensifying type 2 diabetes therapy beyond metformin, choosing between adding an oral DPP-4 inhibitor or starting basal insulin.
结论
Linagliptin suits most as a convenient oral add-on, while insulin degludec is better when stronger glucose control is required.
全部药物对比